Clinical AI in 2026: Med-Gemini, Meditron-3, and the Gap Between Regulated and Accurate

A Nature Medicine benchmark published in June 2026 found that general-purpose chatbots — not FDA-cleared clinical AI — gave the more accurate answers to real physician questions. For a movement founded by a physician, that finding is not a curiosity. It is the whole regulatory gap in one sentence. This is the fourth article inContinue reading “Clinical AI in 2026: Med-Gemini, Meditron-3, and the Gap Between Regulated and Accurate”

Rewriting the Blueprint, Responsibly: How AI and Robotics Will Advance Medicine and Guide Genetic Health

Patients with rare genetic diseases often wait five to seven years for a diagnosis, and new drugs still take over a decade to reach a patient. LIWARSE, from a physician’s chair, looks at how AI and robotics can compress that timeline — and why editing the human genome demands a caution that has nothing to do with the pace of the technology.